Cyclin D1 overexpression as a prognostic factor in patients with esophageal carcinoma. 2001

S Nagasawa, and M Onda, and K Sasajima, and H Makino, and K Yamashita, and K Takubo, and M Miyashita
Department of Surgery I, Nippon Medical School, Tokyo, Japan. nshigeo@hh.iij4u.or.jp

OBJECTIVE Cyclin D1 is known to play important roles in the G1/S check-point of the cell cycle. We investigated the correlation between cyclin D1 overexpression and clinical characteristics to clarify its prognostic significance in patients with esophageal cancer. METHODS From 1991 to 1998, cyclin D1 was investigated in esophageal cancers from 86 patients who underwent esophagectomy. Overexpression of cyclin D1 was demonstrated using an immunohistochemical method. RESULTS Overexpression of cyclin D1 was found in 23 (26.7%) of 86 cases. Overexpression of cyclin D1 correlated with lymph node metastasis (P = 0.0083) and lymphatic vessel invasion (P = 0.018). Cyclin D1 overexpression may indicate resistance to chemotherapy. The patients with cyclin D1 overexpression had a significantly lower survival rate than those without overexpression (P = 0.013). The multivariate analysis revealed cyclin D1 overexpression to be an important prognostic factor in patients with esophageal cancer. CONCLUSIONS Immunohistochemical examination of cyclin D1 expression may provide important prognostic information in univariate and multivariate analysis and may be necessary for determining therapeutic strategies for esophageal cancer.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D004938 Esophageal Neoplasms Tumors or cancer of the ESOPHAGUS. Cancer of Esophagus,Esophageal Cancer,Cancer of the Esophagus,Esophagus Cancer,Esophagus Neoplasm,Neoplasms, Esophageal,Cancer, Esophageal,Cancer, Esophagus,Cancers, Esophageal,Cancers, Esophagus,Esophageal Cancers,Esophageal Neoplasm,Esophagus Cancers,Esophagus Neoplasms,Neoplasm, Esophageal,Neoplasm, Esophagus,Neoplasms, Esophagus
D005260 Female Females

Related Publications

S Nagasawa, and M Onda, and K Sasajima, and H Makino, and K Yamashita, and K Takubo, and M Miyashita
June 1998, The Journal of laryngology and otology,
S Nagasawa, and M Onda, and K Sasajima, and H Makino, and K Yamashita, and K Takubo, and M Miyashita
January 2012, Cancer biomarkers : section A of Disease markers,
S Nagasawa, and M Onda, and K Sasajima, and H Makino, and K Yamashita, and K Takubo, and M Miyashita
April 2011, The Indian journal of medical research,
S Nagasawa, and M Onda, and K Sasajima, and H Makino, and K Yamashita, and K Takubo, and M Miyashita
January 2023, Northern clinics of Istanbul,
S Nagasawa, and M Onda, and K Sasajima, and H Makino, and K Yamashita, and K Takubo, and M Miyashita
April 2001, Liver,
S Nagasawa, and M Onda, and K Sasajima, and H Makino, and K Yamashita, and K Takubo, and M Miyashita
February 2000, International journal of oncology,
S Nagasawa, and M Onda, and K Sasajima, and H Makino, and K Yamashita, and K Takubo, and M Miyashita
January 1997, Japanese journal of cancer research : Gann,
S Nagasawa, and M Onda, and K Sasajima, and H Makino, and K Yamashita, and K Takubo, and M Miyashita
October 1996, Clinical cancer research : an official journal of the American Association for Cancer Research,
S Nagasawa, and M Onda, and K Sasajima, and H Makino, and K Yamashita, and K Takubo, and M Miyashita
February 1999, Virchows Archiv : an international journal of pathology,
S Nagasawa, and M Onda, and K Sasajima, and H Makino, and K Yamashita, and K Takubo, and M Miyashita
January 2018, OncoTargets and therapy,
Copied contents to your clipboard!